PDF
Citation
Print
INTRODUCTION
Gentamicin is a broad-spectrum aminoglycoside antibiotic, which is commonly used worldwide. Though the development of many less toxic antibiotics, the aminoglycoside antibiotics are still indispensable in the treatment of some life threatening enterococcal, mycobacterial, and gram negative infections [1-5]. Cochlear, vestibular, and renal impairments are well-known complications [1]. These complications restrict the use of aminoglycosides. A potential therapeutic modality which would reduce or eliminate these complications, could enable more widespread use of the aminoglycosides [6].
The probable reason of aminoglycoside ototoxicity is inner ear damage by reactive oxygen species [4,7]. Reduction of ototoxicity obtained by cotherapy with free radical scavengers, antioxidants, or iron chelators supports this most widely accepted hypothesis [8]. Garlic (Allium sativum), garlic extracts, and some garlic constituents have intrinsic antioxidant activity. This antioxidant activity has been reported in in vivo and in vitro studies [9-11]. The active compounds of garlic (S-allyl cysteine [SAC], S-allylmercaptocysteine [SAMC], diallyl disulfide [DD], alliin, and allicin) have antioxidant effects [5,6,12,13].
Garlic and its purified constituents have been shown to protect against nephrotoxicity. The attenuator effect of gentamicininduced oxidative stress and nephrotoxicity of garlic [6], aged garlic extract [5], garlic oil [14], DD [12], SAC [13], and SAMC [15] have been demonstrated. It has been shown that, the reduction in gentamicin nephrotoxicity caused by garlic is not due to diminution of renal gentamicin concentration [6]. The effect of garlic on gentamicin induced ototoxicity has not been studied yet except our previous study [16]. We found that, garlic supplemented diet attenuates gentamicin induced ototoxicity in an experimental study. Garlic has many ingredients. The active compound, which is mainly responsible for attenuator effect of garlic gentamicin-induced ototoxicity, is not known and needs to be clarified. In this study, we have investigated the effect of SAMC, DD, and SAC, which are active compounds of garlic on gentamicin-induced ototoxicity in rats by using brainstem evoked response audiometry (BERA).
MATERIALS AND METHODS
Thirty male healthy active Wistar rats, initially weighing 220–260 g were used. Animals were randomly assigned to either the gentamicin injection with SAMC treatment group (Genta-w SAMC), DD treatment group (Genta-w DD), SAC treatment group (Genta-w SAC), gentamicin injection without any active compounds (AC) treatment group (Genta-w/o AC), or control group (n=6 rats each group).
The investigation was approved by Ethics Committee of Marmara University Animal Center (DEHAMER) (protocol code: 72.2012.mar). This study was conducted in DEHAMER.
Diet
All of groups were fed with commercial rodent diet (standard laboratory rodent diet). All animals had free access to water and food. The amount of chow consumption was noted for each group. The health condition and diet of the rats was under strict control throughout the study.
Animals
The rats were supplied from DEHAMER. Animals were not accepted into the study unless they had bilateral normal Preyers’ reflexes and translucent tympanic membrane upon endoscopic examination. Gentamicin was given 120-mg/kg body weight, intraperitoneally once daily for twenty-five days to subjects in Genta-w SAMC, Genta-w DD, Genta-w SAC, and Genta-w/o AC groups. SAMC 100-mg/kg and DD 50-mg/kg body weight were given intragastrically, and SAC 250-mg/kg body weight was given intraperitoneally, once daily to subjects in Genta-w SAMC, Genta-w DD, and Genta-w SAC groups, respectively during the study. In Genta-w/o AC group, rats were fed with standard rodent diet and were not treated with any of active compounds of garlic. Gentamicin and any of active compounds were not given to control group. Control group fed with standard rodent diet. All animals had free access to water and food. The weight of each rat was controlled at the beginning and the end of the study.
Reagents
Active compound of garlic (SAMC, DD, and SAMC) were obtained from Wakunaga Pharmaceutical Co. Ltd., Hiroshima, Japan. Gentamicin was from İ.E. Ulagay İlaç Sanayii Türk A.Ş., Istanbul, Turkey.
Auditory threshold measurement
Thresholds were determined for each animal on 25th day by using BERA. Rats were anaesthetized with ketamine (100 mg/kg) and klorpromazin (5 mg/kg) mixture given intraperitoneally as an induction anesthesia. Ketamin 35-mg/kg and klorpromazin 2-mg/kg mixture were given intramuscular as a maintenance therapy. Auditory thresholds were measured by using evoked auditory brainstem response. BERA recordings were performed in a sound-proof booth. In brief, click stimulus (20-msec duration, 1-msec fall time, low pass filter 100 Hz, high pass filter 3 kHz, and stimulus repetitions 1,500) generated using a Medelec Synergy EMG and EP Systems software ver. 11.0 (VIASYS Healthcare, Madison, WI, USA) and presented to ears via a headphone—Telephonics TDH-49P (VIASYS Healthcare). The active electrode was placed at the vertex, in the midline of the scalp between the external auditory canals. The reference electrode was placed subcutaneously below the pinna of the left ear, and the ground electrode was inserted to the contralateral side. The average responses from 1,024 stimuli were obtained at 10-dB intervals near threshold. The lowest stimulus level at which a positive waveform in the evoked response trace was evident was recorded as the threshold level. The BERA of each animal was performed and interpreted—without knowledge of the treatment history of rats—by 3 researchers (LU, NK, and MTK).
Statistics
Mean±SD were calculated for auditory thresholds of the three groups. Kruskal-Wallis test was used as a non-parametric test to compare all 5 groups for the statistical analysis. A P-value lower than 0.05 was required for statistical significance for Kruskal-Wallis test. Bonferroni adjusted Mann-Whitney U-test was used for post hoc analysis in order to compare the groups as pairs. A P-value lower than 0.016 (0.05/3) was required for statistical significance for Bonferroni adjusted Mann-Whitney U-test. IBM SPSS Statistics ver. 21.0 program (IBM Co., Armonk, NY, USA) was used for statistical analysis.
RESULTS
The amount of total chow consumed throughout the study was almost the same for each group. The weight of each rat was noted at the beginning and the end of the study. We did not detect any meaningful difference regarding the weight of each rat at the beginning and at the end of the study. Two animals were lost from Genta-w/o and control groups during anesthesia. All of the remaining animals underwent final hearing evaluation by using BERA and Preyer’s reflex.
After the tenth day, hearing was evaluated by the Preyer’s reflex daily. By the 25th day the reflex was absent in all members of Genta-w/o AC group animals but present in all control group, Genta-w SAMC, Genta-w DD, and Genta-w SAC group animals.
The mean amplitude of auditory thresholds (sensation level [SL]) measured by using BERA for the Genta-w SAMC, Gentaw DD, Genta-w SAC, Genta-w/o AC, and control groups were 22±8, 25±5, 30±9, 54±11, and 10±7 dB SL, respectively (mean±SD) (Fig. 1). Hearing thresholds are presented in Table 1. Kruskal-Wallis test was used as a non-parametric test to compare all 5 groups for the statistical analysis. The differences were statistically significant (P=0.001).
Bonferroni adjusted Mann-Whitney U-test was used for post hoc analysis to compare the groups as pairs. There were significant differences between the Genta-w SAMC and Genta-w/o AC, Genta-w DD and Genta-w/o AC and between the Genta-w SAC and the Genta-w/o AC groups (P=0.008, P=0.004, P=0.009, respectively). A P-value lower than 0.016 (0.05/3) was required for statistical significance for Bonferroni adjusted Mann-Whitney U-test. There weren’t any significant differences found when we compared the three agents as pairs i.e., SAMC vs. DD, SAMC vs. SAC, and DD vs. SAC (P>0.05).
DISCUSSION
In this study we found that all the three active compounds—i.e., SAMC, DD, and SAC—attenuated gentamicin ototoxicity compared to controls. None of the 3 compounds was superior to another regarding this attenuation effect.
The main limiting factors of clinical usage of gentamicin are renal, cochlear, and vestibular complications. If a potential therapeutic option to reduce these complications could be found, gentamicin would become a more widely used antibiotic [1,6]. Attenuator effects of supplemented garlic diet on gentamicin induced renal damage, and ototoxic effect were proved in previous studies [6,16,17].
Aminoglycoside antibiotics forms a complex with oxidative properties by chelating iron and thus promote the formation of free radicals. It has been shown that free radicals are responsible for production of lesions in the hair cells, especially in the outer hair cells [3]. Aminoglycoside induced destruction of the sensory and supporting cells of the organ of Corti ensues starting with the outer hair cells of the lower turns and progressing to the apex, systematically [1,2,18]. It has been concluded that the generation of reactive oxygen species (ROS) is linked to ototoxicity. The aminoglycosides lead to the formation of ROS as observed in vitro as well as in cell culture studies. ROS is known to be very harmful to biological tissues via lipid peroxidation, DNA strand breaks, carbohydrate and protein damage, and deranged membrane-bound enzymes and receptors [2].
Prevention of gentamicin induced ototoxicity is maintained by either of two ways. Firstly, aminoglycosides react with iron to generate ROS. Protection against ototoxicity thus may be achieved by reducing the availability of iron by using chelators, such as deferoxamine and dihydroxybenzoate and these are shown to be effective in preventing from aminoglycoside ototoxicity. Secondly, antioxidants may be used protect the cochlea. They are shown to be effective against aminoglycoside ototoxicity in experimental animal studies, including lipoic acid, D-methionine, salicylates, and dihydroxybenzoate [2,18].
Several in vivo and in vitro studies have shown the intrinsic antioxidant activity of garlic (Allium sativum), garlic extracts, garlic oil and some garlic constituents [6,9-14,19-21]. Little data is available from scientific studies concerning the bioavailability of garlic-derived compounds. The bioavailability of SAC is 98% in rats [22]. Unfortunately, no pharmacokinetic data are available for SAMC. Three in vivo studies showed that oral administration of SAMC (200 mg/kg) decreased acetaminophen-induced liver injury in mice, and attenuates gentamicin-induced renal damage and thus indicating the bioavailability of orally administrated SAMC [15,23,24]. Diallyl sulfures and vinyldithiins are the major components of garlic oil and oil-macerate preparations. Vinyldithiins have been detected in the serum, kidney and fat tissue >24 hours after oral ingestion [19]. Synthesized S-labeled alliin, 60%–70% was absorbed in rats [21]. It was found that alliin along with DD could be detected in the perfusate after the isolated rat liver passage, but no allicin was found [25]. These findings indicate that alliin itself is never converted to allicin in the body and metabolized to various organosulfur compounds such as DD by liver enzymes [19].
Renal damage induced by gentamicin has been shown to be decreased by the garlic diet. The beneficial effect was not due to a decrease in renal gentamicin concentration, but rather was due to the prevention of the decrease of manganese-containing superoxide dismutase (Mn-SOD) and glutathione peroxidase (GPx) activities and the rise of lipoperoxidation in renal cortex observed in gentamicin nephrotoxicity [6]. Maldonado et al. [5] have shown in rats treated with gentamicin that aged garlic extract prevented the increase in carbonyl and nitrotyrosine levels in renal cortex. The effect could be associated with the antioxidant properties of aged garlic extract, and with its ability to prevent the decrease in antioxidant enzymes activity (Mn-SOD, GPx, and glutathione reductase). Therefore aged garlic extract contain compounds, which potentially ameliorate gentamicin-induced nephrotoxicity. The compounds responsible of its protective effect are postulated to be S-allylcysteine, allymercaptocysteine, and alliin, which are water soluble, odorless, and have antioxidant properties [5].
The effect of active compounds of garlic on hearing has not been studied yet. In our previous study, we have shown that garlic supplemented diet attenuates the gentamicin induced hearing loss in animals [16]. In this study, we evaluated the protective effect of SAMC, DD, and SAC, which are the active compounds of garlic against gentamicin-induced ototoxicity. In the gentamicin injection with AC groups (Genta-w SAMC, Genta-w DD, and Genta-w SAC), there was a significant reduction of ototoxicity detected by BERA compared to gentamicin injection without AC (Genta-w/o AC) group. Thus, treatment of garlic derivatives (SAMC, DD, and SAC) significantly attenuated aminoglycoside-induced hearing loss in rats as measured by Preyer’s reflex and BERA. The effect of SAMC and DD seems to be more prominent than that of SAC but statistical comparison did not show a significant difference between their effects.
We detected that garlic derivatives (SAMC, DD, and SAC) have an attenuator effect in gentamicin-induced ototoxicity, possibly due to the antioxidant effect of garlic derivatives. The results of this study are rather exciting but it has several limitations. One of them is the small sample size. Secondly the beneficial effect of garlic needs to be shown by controlled human studies. Nevertheless such a simple measure like adding garlic to the diet may be of promise to prevent the irreversible ototoxicity due to aminoglycosides. Many patients may refuse to take garlic powder or fresh garlic due to their pungent odor [5]. Thus the route of administration may involve medical forms that would avoid the pungent odor.
BERA recordings in our study were performed using click stimulus with a high pass filter 3 kHz and stimulus repetitions 1,500 and found better threshold in active compound groups (Genta-w SAMC, Genta-w DD, and Genta-w SAC) than the controls. Presumably it would be wiser if the high pass filter was chosen in the higher values but still we could demonstrate the beneficial effect of the compounds. Also it would be a more comprehensive study if we could add the investigation of the inner hair cells to experiment design. As a conclusion, SAMC, DD, and SAC are derivative of garlic seems to attenuate aminoglycoside-induced hearing loss. The effect of SAMC and DD seems to be more prominent than that of SAC.
HIGHLIGHTS
▪ Ototoxicity is one of the main side effect which restrict the use of Gentamicin.
▪ Garlic with its intrinsic antioxidant activity may beneficial in prevention from ototoxicity.
▪ Garlic derivatives (S-allylmercaptocysteine [SAMC], diallyl disulfide [DD], and S-allylcysteine [SAC]) seems to attenuate gentamicin-induced hearing loss.
▪ The effect of SAMC and DD seems to be more prominent than that of SAC.
XML Download